It was announced today that Lero researchers from the Regulated Research Centre at Dundalk Institute of Technology have launched a new medical device cybersecurity company that plans to create 78 jobs over the next four years.
The Lero DkIT spinout company, Nova Leah, has developed an expert cybersecurity risk management software application aimed at global medical device manufacturers and healthcare providers.
The new cloud based system, SelectEvidence, is designed to guide medical device manufacturers implementing cybersecurity requirements and best practices over the lifetime of device in compliance with US FDA (Food & Drug Administration) recommendations for information security threats and risks during premarket and post market activities.
Nova Leah is initially targeting customers in the imaging and electro medical device sectors in the US, a market that is estimated to be worth $155 billion of which connected devices account for approximately $51 billion. It is estimated that there are more than 6,500 medical device manufacturers in the US.
The company has just opened an office in Boston to serve the North American market. Initial investors include US venture capital company, COSIMO Venture Partners and Enterprise Ireland.
"The recent WannaCry ransomware attack on the UK’s NHS highlights the importance of cybersecurity in the health sector. Today’s medical devices incorporate high levels of software and are connected across networks, online or wirelessly," commented Nova Leah CEO, Anita Finnegan.
"As a result, medical device manufacturers are facing two major challenges: ensuring compliance with stricter regulatory measures and minimising the probability of malicious breaches aimed at medical devices and healthcare IT networks."
Source: www.businessworld.ie
